Search Results 481-490 of 17217 for egfr

1. Pembrolizumab Plus Epacadostat Alone or With Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-715-02/ECHO-306) - Mayo Clinic

   Histologically or cytologically confirmed diagnosis of stage IV NSCLC without epidermal growth factor receptor (EGFR)-sensitizing mutation, ROS1 and/or ...

2. A Study to Evaluate Posoleucel ALVR105 to Treat Kidney Transplant Recipients with BK Viremia - Mayo Clinic

   Renal dysfunction, defined as estimated glomerular filtration rate (eGFR) (estimated by Modified Dose in Renal Disease [MDRD] formula) < 20 mL/min/1.73 m^2.

3. Laminar LAAX Pivotal IDE Study - Mayo Clinic

   Renal insufficiency, defined as estimated glomerular filtration rate (eGFR) \<30 mL/min/1.73 m2 or patients with end stage renal disease who are dialysis ...

4. A Study to Assess the Efficacy and Safety of AVTX-803 in Subjects with Leukocyte Adhesion Deficiency Type II (LAD II) - Mayo Clinic

   - Subject has impaired renal function as defined by an eGFR <90 mL/min - Subject has a total absence of fucosylation on red blood cells and the presence of

5. A Dose Escalation and Expansion Study of ASP4132 to Subjects With Advanced Refractory Tumors and Lymphoma - Mayo Clinic

   Subject has an estimated glomerular filtration rate (eGFr) of < 60ml/min as calculated by the modification of diet Renal disease (MDRD) Equation. Subject ...

6. OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer - Mayo Clinic

   Impaired renal function defined as eGFR< 50 mL/min/1.73m2. Impaired liver function defined as values > 3x the upper limit of normal (ULN) for alanine ...

7. Publications - Yujie Zhao, M.D., Ph.D. - Mayo Clinic

   Role of Immune Checkpoint Inhibitor Therapy in Advanced EGFR-Mutant Non-Small Cell Lung Cancer. Front Oncol. 2021; 11:751209 Epub 2021 Nov 16. View PubMed ...

8. ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation - Mayo Clinic

   Renal insufficiency (creatinine \> 3.0 mg/dL or eGFR \< 30 ml/min/1.73m2) and/or end stage renal disease requiring chronic dialysis 9. Hostile chest or ...

9. A Platform Protocol for Evaluation of Interventions for Autonomic Dysfunction in Post-Acute Sequelae of SARS-CoV-2 Infection - Mayo Clinic

   Known renal failure (eGFR <20ml/1.73 m²). Known atrial fibrillation or significant cardiac arrhythmia. Known cardiovascular conditions such as heart failure ...

10. A Phase 1/2 Trial Of TER-2013 In Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations - Mayo Clinic

    * Known EGFR, KRAS, NRAS, HRAS, or BRAF oncogenic-driver co-mutation with PI3K/AKT/PTEN alteration * Clinically significant abnormalities of glucose metabolism